This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hatsukami, D. K. Articles by Hecht, S. S. Search for Related Content PubMed PubMed Citation Articles by Hatsukami, D. K. Articles by Hecht, S. S. Related Collections Oncogenesis Oncogenesis: Biomarkers

Toxicant Exposure in Cigarette Reducers versus Light Smokers

University of Minnesota Transdisciplinary Tobacco Use Research Center and the Cancer Center, Minneapolis, Minnesota

Requests for reprints: Dorothy K. Hatsukami, Tobacco Use Research Center, University of Minnesota, 2701 University Avenue Southeast, #201, Minneapolis, MN 55414. Phone: 612-627-1808; Fax: 612-627-4899. E-mail: hatsu001{at}umn.edu

Background: The extent of exposure to tobacco toxicants in smokers who have reduced their cigarette intake compared with smokers who are light smokers is relatively unknown. The goal of this study is to investigate the occurrence of compensatory smoking in reducers compared with light smokers by measuring toxicant exposure.

Methods: Participants in two smoking reduction intervention studies (N = 64) were selected for comparison with a group of light smokers (N = 62) who smoked the same number of cigarettes as the reducers. A compensatory smoking score was defined (biomarker level for reducer/biomarker level for light smoker) and calculated for urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (total NNAL), metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-I-(3-pyridyl)-1-butanone, to measure the degree of smoking compensation in reducers when compared with the light smokers.

Results: The mean level of creatinine-adjusted total NNAL for reducers was over twice that of light smokers even when they smoked about the same number of cigarettes per day. The difference of the mean total NNAL concentrations between light smokers and reducers was highly significant (P < 0.0001). Wide variability in total NNAL concentrations was also observed in reducers, with the extent of this variability between light smokers and reducers being significantly different (P = 0.0005). The level of individual reduction was shown to be a consistent predictor of compensatory smoking (r = 0.50; adjusted Ps = 0.002), with greater cigarette reduction associated with more compensation.

Conclusions: Compensatory smoking limits the harm reduction value of decreased smoking of cigarettes. (Cancer Epidemiol Biomarkers Prev 2006;15(12):2355–8)

This article has been cited by other articles:

				A P Polednak Tobacco control indicators and lung cancer rates in young adults by state in the United States Tob. Control, January 1, 2008; 17(1): 66 - 69. [Abstract] [Full Text] [PDF]

				A. Hoque, H. L. Parnes, M. E. Stefanek, J. V. Heymach, P. H. Brown, and S. M. Lippman Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention Research Cancer Res., October 1, 2007; 67(19): 8989 - 8993. [Abstract] [Full Text] [PDF]